The Women's HIV SeroIncidence Study (ISIS)
Completed
Conditions studied: HIV Infections
In brief
Approximately 30 percent of new HIV infections in the Unites States occur in women, with a disproportionate number occurring in women of color. This observational study has been designed to help determine the HIV incidence among women in the study communities as well as to identify steps that women can take to lower their HIV-infection risk.
Key facts
- Study ID
- NCT00995176
- Run by
- HIV Prevention Trials Network
- People needed
- 2099
- Starts
- 2009-04-01
- Expected to finish
- 2011-03-01
- Last updated by the study team
- 2022-08-30
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
Where it is running
- George Washington University — Washington D.C., District of Columbia, United States
- The Ponce de Leon Center — Atlanta, Georgia, United States
- Hope Clinic of the Emory Vaccine Center — Decatur, Georgia, United States
- Johns Hopkins Adult AIDS CRS — Baltimore, Maryland, United States
- New Jersey Medical School- Adult Clinical Research Ctr. CRS — Newark, New Jersey, United States
- Harlem Prevention Ctr. CRS — New York, New York, United States
- Bronx- Lebanon Hospital Center Clinical Research Site — The Bronx, New York, United States
- Unc Aids Crs — Chapel Hill, North Carolina, United States
- Wake County Health and Human Services — Raleigh, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.